Gillian Mahumane | Pharmaceutical science | Best Researcher Award

Dr. Gillian Mahumane | Pharmaceutical science | Best Researcher Award

Lecturer at University of the Witwatersrand, South Africa

Dr. Gillian D. Mahumane is a pharmaceutical scientist and lecturer whose research advances neural-targeted and vaginal drug delivery systems with a strong focus on translational pharmaceutics and global health impact. Her work spans innovative platforms such as antimicrobial cryogels, polymeric films, and nanofiber scaffolds for applications in neural repair and women’s health. She has published extensively in peer-reviewed journals, contributed to book chapters, and presented at international conferences, establishing her as a thought leader in advanced drug delivery. Beyond research, she is deeply committed to mentorship, supervising postgraduate students, co-founding research support initiatives, and shaping biopharmaceutics curricula to bridge science and practice. Recognition through prestigious fellowships and membership in the Global Young Academy highlights her growing leadership in science communication, innovation management, and policy engagement. Combining scientific excellence, mentorship, and advocacy, Dr. Mahumane exemplifies a new generation of researchers dedicated to advancing biomedical innovation and societal health impact.

Professional Profile 

Google Scholar | Scopus Profile | ORCID Profile 

Education

Dr. Gillian D. Mahumane has built a solid academic foundation in pharmaceutical sciences through progressive qualifications at the University of the Witwatersrand. She completed her Bachelor of Pharmacy, where her early research explored drug delivery using polycaprolactone-based systems. Building on this, she earned her Master of Pharmacy with distinction, focusing on the antimicrobial activity and chemical analysis of Eucalyptus radiata essential oil, which deepened her expertise in natural products and pharmaceutical analysis. Her doctoral studies marked a significant step into advanced biomaterials and regenerative medicine, culminating in a PhD in which she designed and evaluated nano-reinforced hydro-filled 3D scaffolds for neural tissue engineering. This multidisciplinary training equipped her with expertise in pharmaceutics, biomaterials, and pharmacokinetics, forming the basis for her later research into neural-targeted and vaginal drug delivery platforms. Her academic journey reflects both depth in specialized research and breadth across pharmaceutical sciences, positioning her for leadership in translational pharmaceutics.

Experience

Dr. Gillian Mahumane is a lecturer in biopharmaceutics and a researcher with the Wits Advanced Drug Delivery Platform, where she combines teaching, mentorship, and cutting-edge research. Her role encompasses supervising postgraduate projects, integrating research into curriculum design, and driving institutional research support strategies. She has gained valuable international experience through fellowships with the Population Council’s Centre for Biomedical Research in New York, focusing on vaginal drug delivery innovation, and the UCL-Wits Public Voices Fellowship, which enhances her leadership in science communication. In addition to her academic contributions, she has engaged in policy-linked research initiatives and co-founded a research support group that mentors over thirty postgraduate students. Her professional journey is defined by a balance of laboratory innovation, translational research, and capacity building. Through these roles, she has cultivated expertise not only as a scientist but also as an educator, mentor, and emerging leader in pharmaceutical innovation and global health.

Research Focus

Dr. Gillian Mahumane’s research is anchored in translational pharmaceutics, particularly neural-targeted and vaginal drug delivery systems designed to address unmet clinical needs. She has explored advanced biomaterials, including nanofiber scaffolds, polymeric films, and antimicrobial cryogels, with applications ranging from brain tissue regeneration to intravaginal microbicide delivery. Her doctoral research pioneered nano-reinforced hydro-filled 3D scaffolds for neural repair, addressing challenges in tissue engineering and regenerative medicine. More recently, she has advanced vaginal platforms for multipurpose prevention technologies, integrating biopharmaceutics and global health perspectives. Complementing these laboratory innovations, she contributes to pharmacokinetics research, designing teaching models and patient-centered dosage regimens. Her focus extends beyond discovery to translation, aiming to move research outputs into real-world applications that improve health outcomes. By integrating pharmaceutical sciences, biomaterials engineering, and policy engagement, her research not only contributes to academic knowledge but also supports broader societal impact in women’s health and neurotherapeutics.

Award and Honor

Dr. Gillian Mahumane has been recognized with multiple awards and fellowships that underscore both her scientific excellence and her emerging leadership in global health research. She is a member of the Global Young Academy, an honor that acknowledges her as a voice for African biomedical innovation and positions her within an influential international network of scientists. Her selection as a CBR/Jeiven Fellow at the Population Council in New York highlighted her contributions to vaginal drug delivery innovation, while her UCL-Wits Public Voices Fellowship reflects her strength in science communication and policy engagement. She has also been featured in initiatives promoting women in science, innovation in pharmaceutical education, and capacity building in Africa. Beyond formal fellowships, her research and teaching have been showcased through institutional awards, invited talks, and international conference presentations. These recognitions emphasize not only her scholarly achievements but also her commitment to mentorship, innovation, and societal health impact.

Publication Top Notes

Title: 3D scaffolds for brain tissue regeneration: architectural challenges
Authors: GD Mahumane, P Kumar, LC du Toit, YE Choonara, V Pillay
Year: 2018
Citations: 90

Title: Repositioning N-Acetylcysteine (NAC): NAC-Loaded Electrospun Drug Delivery Scaffolding for Potential Neural Tissue Engineering Application
Authors: GD Mahumane, P Kumar, V Pillay, YE Choonara
Year: 2020
Citations: 29

Title: Chemical composition and antimicrobial activity of Eucalyptus radiata leaf essential oil, sampled over a year
Authors: GD Mahumane, SF van Vuuren, G Kamatou, M Sandasi, AM Viljoen
Year: 2016
Citations: 13

Title: Impact of illegible prescriptions on dispensing practice: a Pilot Study of South African Pharmacy Personnel
Authors: T Modi, N Khumalo, R Shaikh, Z Booth, S Leigh-de Rapper, GD Mahumane
Year: 2022
Citations: 9

Title: Antimicrobial activity and chemical analysis of Eucalyptus radiata leaf essential oil
Author: GD Mahumane
Year: 2016
Citations: 5

Title: A review of bigels for neurotrauma therapeutics: Structural insights for tissue microenvironment alignment
Authors: YC Botle Moswatsi, GD Mahumane, Pradeep Kumar
Year: 2025
Citations: 1

Title: The potential for Eucalyptus radiata leaf essential oil use as a commercial antimicrobial
Authors: GD Mahumane, SF van Vuuren, AM Viljoen, G Kamatou
Year: 2015
Citations: 1

Title: A Dual-Template Molecularly Imprinted Polymer to Inhibit Quorum Sensing Molecules: Theoretical Design, Optimized Synthesis, Physicochemical Characterization and Preliminary Analysis
Authors: PL Khonzisizwe Somandi, TS Mwale, M Sobiech, D Klejn, GD Mahumane, YE Choonara, J Giebułtowicz, P Luliński
Year: 2025

Title: Bio-inspired nanofibres: Weaving biological tissue with nanomedicine to repair brains
Authors: GD Mahumane, YE Choonara
Year: 2022

Title: Nano-enabled systems for neural tissue regenerative applications
Authors: GD Mahumane, P Kumar, YE Choonara
Year: 2022

Title: Nano-reinforced hydro-filled 3D scaffold for neural tissue engineering (PhD Thesis)
Author: GD Mahumane
Year: 2021

Conclusion

Dr. Gillian D. Mahumane has established a strong and growing research portfolio in pharmaceutical sciences, with particular strengths in neural tissue engineering, vaginal drug delivery platforms, and biomaterials innovation. Her most-cited works, such as those on 3D scaffolds for brain tissue regeneration and electrospun drug delivery systems, highlight her contributions to advancing regenerative medicine and translational pharmaceutics. In addition, her studies on natural products and antimicrobial applications demonstrate her versatility across pharmaceutical research domains. While some of her most recent publications are still in the early stages of gaining citations, they reflect cutting-edge directions in drug delivery and biomedical innovation. Taken together, her body of work illustrates both academic impact and practical relevance, positioning her as a promising and influential researcher. With continued advancement of her translational outputs and expanded global collaborations, Dr. Mahumane is well-placed to make sustained contributions worthy of recognition through research excellence awards.

Dr. Christian Seebauer | Pharmacology | Best Researcher Award

Dr. Christian Seebauer | Pharmacology | Best Researcher Award

Senior Consultant at Department of Oral and Maxillofacial Surgery / Plastic surgery, University Medicine Lübeck, Germany

Dr. med. Christian Seebauer, MD, DDS, is a distinguished clinician-scientist with dual qualifications in medicine and dentistry and board certifications in Oral and Maxillofacial Surgery and Oral Surgery. Currently a Senior Consultant at University Medical Center Lübeck, he has held several leadership roles in academic surgery. His research focuses on innovative therapies such as cold atmospheric plasma for cancer, wound healing, and oral diseases. He has authored impactful publications in high-ranking journals, with a strong emphasis on translational and interdisciplinary research. Awarded a summa cum laude for his medical doctorate, he is pursuing a second doctorate in dental medicine and a habilitation. Dr. Seebauer is actively involved in clinical trials, academic teaching, and scientific advising. His work reflects a commitment to advancing patient care through science, collaboration, and clinical excellence, making him a highly suitable candidate for prestigious research recognition such as the Best Researcher Award.

Professional Profile 

Google Scholar
Scopus Profile

Education

Dr. Christian Seebauer’s educational background reflects his exceptional commitment to interdisciplinary medical science. He earned his medical degree from Friedrich-Schiller-University Jena in 2006, graduating with high distinction and obtaining his medical license with a “very good” grade. Driven by an interest in craniofacial care, he pursued a second degree in dentistry at Ernst-Moritz-Arndt-University Greifswald, earning his dental license in 2015, again with top marks. He completed specialist training in Oral and Maxillofacial Surgery (2020) and Oral Surgery (2021), and is on track to receive an additional qualification in Plastic and Aesthetic Surgery by 2025. Academically, he achieved his Doctor of Medicine (summa cum laude) from Charité – Berlin in 2012, is completing a second doctorate in dental medicine, and is preparing his habilitation at University Medical Center Lübeck. His dual training uniquely equips him for complex surgical, academic, and translational roles in modern healthcare.

Professional Experience

Dr. Seebauer has accumulated extensive clinical and academic experience in leading German medical institutions. He began his residency in musculoskeletal surgery at Charité – Berlin (2007–2010), then transitioned into Oral and Maxillofacial Surgery at University Medical Centers in Jena and Greifswald. At Greifswald, he steadily advanced from resident to Specialist, then Senior Consultant, and eventually Managing Senior Consultant by 2023. In August 2024, he was appointed Senior Consultant at the University Medical Center Lübeck. Throughout his career, he has taken on multiple responsibilities beyond patient care, including roles in transfusion medicine, radiation safety, and medical coding. Dr. Seebauer is experienced in running clinical trials, mentoring young surgeons, and integrating advanced surgical techniques such as microvascular tissue transfer and plasma-based therapies. His professional trajectory demonstrates continuous growth in clinical leadership, academic excellence, and institutional trust, confirming his status as a respected authority in surgical and translational medicine.

Research Interest

Dr. Seebauer’s research centers on innovative, translational approaches to oral, mucosal, and dermal disease management, with a particular emphasis on cold atmospheric plasma. His work spans a range of high-impact medical themes, including wound healing, cancer therapy, precancerous lesions, chronic inflammation, and alternative cancer treatments. He has contributed significantly to both preclinical and clinical investigations, exploring how plasma technologies can improve outcomes in head and neck cancer, oral lichen planus, and leukoplakia. His recent studies include cohort analyses on the effects of anticoagulants on wound healing and the global impact of HPV vaccination on malignancy risks. He is actively involved in the planning of prospective, multicenter clinical trials and collaborates internationally via networks like TriNetX. His multidisciplinary approach combines surgery, oncology, immunology, and biomedical engineering, showcasing his ability to merge clinical insight with experimental innovation. These interests place him at the forefront of translational medical research in Europe.

Award and Honor

Dr. Christian Seebauer has earned several distinctions throughout his academic and clinical career. He was awarded his Doctor of Medicine degree summa cum laude, one of the highest academic honors in Germany, by the prestigious Charité – University Medical Center Berlin. His scientific work has been published in internationally renowned, peer-reviewed journals such as Radiology, Oral Diseases, and Pharmacological Research, some with impact factors exceeding 10. He has held trusted leadership roles, including Managing Senior Consultant, and serves as a Scientific Advisor to neoplas MED. His selection for these positions reflects institutional recognition of his scientific and clinical integrity. Although not explicitly listed, his rising trajectory in academic medicine and involvement in high-level research projects suggest a strong reputation within professional circles. His affiliations with organizations such as the National Center for Plasma Medicine and Rotary Club also highlight his commitment to service and excellence beyond his clinical duties.

Conclusion

Dr. Christian Seebauer exemplifies the ideal candidate for recognition as a Best Researcher. With dual qualifications in medicine and dentistry, a track record of clinical leadership, and a deep commitment to translational research, he bridges the gap between scientific discovery and patient care. His pioneering work in cold atmospheric plasma and its applications in oncology and regenerative medicine is both innovative and impactful, reflecting future-forward thinking in clinical science. His publication record, leadership roles, and collaborative involvement in global research initiatives further establish his credibility and influence in the medical community. Dr. Seebauer’s academic path—marked by excellence, versatility, and continual advancement—underscores his dedication to improving healthcare through research, education, and clinical innovation. As he continues his habilitation and leads new clinical trials, his contributions are poised to shape future standards in surgery and therapeutic technology. He is highly deserving of prestigious accolades such as the Best Researcher Award.

Publications Top Notes

  • Title: Clinical experience with cold plasma in the treatment of locally advanced head and neck cancer

    • Authors: HR Metelmann, C Seebauer, V Miller, A Fridman, G Bauer, DB Graves, …

    • Year: 2018

    • Citations: 353

  • Title: Head and neck cancer treatment and physical plasma

    • Authors: HR Metelmann, DS Nedrelow, C Seebauer, M Schuster, T von Woedtke, …

    • Year: 2015

    • Citations: 256

  • Title: Molecular mechanisms of the efficacy of cold atmospheric pressure plasma (CAP) in cancer treatment

    • Authors: ML Semmler, S Bekeschus, M Schäfer, T Bernhardt, T Fischer, K Witzke, …

    • Year: 2020

    • Citations: 216

  • Title: Comprehensive clinical plasma medicine: cold physical plasma for medical application

    • Authors: HR Metelmann, T Von Woedtke, KD Weltmann

    • Year: 2018

    • Citations: 162

  • Title: Visible tumor surface response to physical plasma and apoptotic cell kill in head and neck cancer

    • Authors: M Schuster, C Seebauer, R Rutkowski, A Hauschild, F Podmelle, …

    • Year: 2016

    • Citations: 152

  • Title: Cold atmospheric pressure plasma in wound healing and cancer treatment

    • Authors: L Boeckmann, M Schäfer, T Bernhardt, ML Semmler, O Jung, G Ojak, …

    • Year: 2020

    • Citations: 100

  • Title: Treating cancer with cold physical plasma: On the way to evidence‐based medicine

    • Authors: HR Metelmann, C Seebauer, R Rutkowski, M Schuster, S Bekeschus, …

    • Year: 2018

    • Citations: 65

  • Title: Hyperspectral imaging for in vivo monitoring of cold atmospheric plasma effects on microcirculation in treatment of head and neck cancer and wound healing

    • Authors: R Rutkowski, M Schuster, J Unger, C Seebauer, HR Metelmann, …

    • Year: 2017

    • Citations: 58

  • Title: Ankle laxity: stress investigation under MRI control

    • Authors: CJ Seebauer, HJ Bail, JC Rump, B Hamm, T Walter, UKM Teichgräber

    • Year: 2013

    • Citations: 55

  • Title: Side effects in cold plasma treatment of advanced oral cancer—Clinical data and biological interpretation

    • Authors: M Schuster, R Rutkowski, A Hauschild, RK Shojaei, T von Woedtke, …

    • Year: 2018

    • Citations: 48

  • Title: Physical plasma and leukocytes–immune or reactive?

    • Authors: S Bekeschus, C Seebauer, K Wende, A Schmidt

    • Year: 2018

    • Citations: 42

  • Title: Plasmamedizin

    • Authors: HR Metelmann, T von Woedtke, KD Weltmann

    • Year: 2016

    • Citations: 42

  • Title: Cold argon plasma as adjuvant tumour therapy on progressive head and neck cancer: A preclinical study

    • Authors: S Hasse, C Seebauer, K Wende, A Schmidt, HR Metelmann, …

    • Year: 2019

    • Citations: 41

  • Title: Third molars and periodontal damage of second molars in the general population

    • Authors: S Kindler, B Holtfreter, T Koppe, M Mksoud, C Lucas, C Seebauer, …

    • Year: 2018

    • Citations: 36

  • Title: Plasma-derived reactive species shape a differentiation profile in human monocytes

    • Authors: E Freund, J Moritz, M Stope, C Seebauer, A Schmidt, S Bekeschus

    • Year: 2019

    • Citations: 34